The Knee Surgery Paradox: When Less Might Be More
There’s a quiet revolution happening in orthopedic surgery, and it’s raising some uncomfortable questions. A recent study published in the New England Journal of Medicine has thrown a wrench into the works of a common knee procedure, arthroscopic surgery for degenerative cartilage tears. The findings? It might do more harm than good. Personally, I think this is one of those moments where medicine is forced to confront its own assumptions—and it’s about time.
The Procedure Under the Microscope
Arthroscopic knee surgery, often performed to trim degenerative cartilage tears, has been a go-to solution for middle-aged and older patients with chronic knee pain. But here’s the kicker: the study found that patients who underwent the surgery experienced more pain, accelerated osteoarthritis, and higher reoperation rates compared to those who had a sham procedure—literally just a skin incision. What makes this particularly fascinating is that the study deliberately selected patients who were deemed most likely to benefit from the surgery. If even they fared worse, it raises a deeper question: Who, if anyone, should be getting this procedure?
From my perspective, this isn’t just about one study. It’s part of a broader trend in medicine where we’re reevaluating the value of certain interventions. Evidence has been piling up for over a decade that physical therapy is often just as effective—if not more so—than surgery for degenerative knee issues. Yet, the procedure remains popular, especially in the U.S. Why? One thing that immediately stands out is the financial incentive. Surgery is lucrative, both for providers and hospitals. Medicare pays thousands of dollars per procedure, and commercial insurers often pay even more. If you take a step back and think about it, this creates a perverse incentive to operate, even when the evidence suggests it might not be necessary.
The Geography of Overuse
What many people don’t realize is that the rate of this surgery varies wildly by region. In the U.S., it’s far more common in the South than in the Northeast. This isn’t because Southern knees are somehow more prone to degeneration—it’s a reflection of differing medical cultures and, likely, financial motivations. This raises a troubling question: Are patients in some regions being overtreated simply because it’s profitable?
The Role of Guidelines—and Who Writes Them
Here’s where things get even more interesting. Orthopedic specialty societies have been advocating for a more conservative approach, recommending physical therapy before surgery. But they still endorse the procedure, even though the evidence is shaky. Why? Because, as Teppo Järvinen, one of the study’s authors, points out, specialists often create the guidelines for their own treatments. It’s a classic case of the fox guarding the henhouse.
A detail that I find especially interesting is the pushback from groups like the Save the Meniscus Society, which promotes nonsurgical treatments. Their efforts are commendable, but they’re swimming against a strong current. Surgeons are now touting a newer procedure—sewing torn cartilage back together—as a better alternative. But here’s the catch: it’s only suitable for younger patients with acute injuries. What this really suggests is that we’re still grasping for solutions, even as we question the old ones.
The Bigger Picture: When Is Surgery Necessary?
If there’s one takeaway from this debate, it’s that medicine is not always as evidence-based as we’d like to think. Financial incentives, regional practices, and professional biases all play a role in treatment decisions. What this really suggests is that patients need to be more skeptical—and more informed. Just because a procedure is common doesn’t mean it’s effective.
In my opinion, the knee surgery debate is a microcosm of a larger issue in healthcare: the tension between doing what’s best for the patient and doing what’s profitable. As we move forward, we need to ask harder questions about who benefits from these procedures—and who pays the price.
